Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

565 Articles

Chris Lange | Jul 29, 2016 at 9:05 AM EDT

How AbbVie Won Big on Earnings

AbbVie released a better-than-expected second-quarter earnings report before the markets opened on Friday.

Lee Jackson | Jul 29, 2016 at 8:15 AM EDT

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Despite the fact that energy has tumbled 20% from the highs posted in June, Jefferies remains bullish on the natural…

Chris Lange | Jul 28, 2016 at 9:45 AM EDT

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Lee Jackson | Jul 26, 2016 at 8:35 AM EDT

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new…

Douglas A. McIntyre | Jul 24, 2016 at 10:47 AM EDT

Apple Picked as World’s Favorite Company

In a study that ranks “perceived strength” of companies rather than their financial performance, Apple Inc. (NASDAQ: AAPL) took the top…

Chris Lange | Jul 24, 2016 at 10:12 AM EDT

10 Must-See Earnings for the Coming Week

24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting…

Lee Jackson | Jul 16, 2016 at 9:15 AM EDT

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Jun 15, 2016 at 11:05 AM EDT

6 Biopharma Movers Making a Run on Wednesday

24/7 Wall St. has picked out the biggest movers and winners on Wednesday, particularly biopharma companies making serious runs in…

Chris Lange | Jun 14, 2016 at 11:15 AM EDT

Why Infinity Pharmaceuticals Crashed

Though Infinity Pharmaceuticals announced that its DYNAMO study met its primary endpoint of overall response rate, the stock was still…

Lee Jackson | Jun 13, 2016 at 8:15 AM EDT

Analysts Very Positive on 3 Top Stocks Following Jefferies Healthcare Conference

The Jefferies Healthcare Conference wrapped up in New York City last week, and the mood was reported as generally positive,…

Jon C. Ogg | Jun 10, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Abbvie, Amazon, Cliffs Natural, Corning, Dynegy, Joy Global, Stanley Black & Decker and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include Abbvie, Amazon.com, Cliffs Natural Resources, Corning, Dynegy, Joy…

1 … 26 27 28 29 30 … 38

AbbVie : ABBV

All AbbVie Articles

How AbbVie Won Big on Earnings

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Apple Picked as World’s Favorite Company

10 Must-See Earnings for the Coming Week

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Short Sellers Run for Cover From Major Pharma

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

6 Biopharma Movers Making a Run on Wednesday

Why Infinity Pharmaceuticals Crashed

Analysts Very Positive on 3 Top Stocks Following Jefferies Healthcare Conference

Top Analyst Upgrades and Downgrades: Abbvie, Amazon, Cliffs Natural, Corning, Dynegy, Joy Global, Stanley Black & Decker and More

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

AbbVie : ABBV

All AbbVie Articles

How AbbVie Won Big on Earnings

Jefferies Makes Key Changes to Top Energy Stocks in Franchise Picks Portfolio

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Apple Picked as World’s Favorite Company

10 Must-See Earnings for the Coming Week

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Short Sellers Run for Cover From Major Pharma

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

6 Biopharma Movers Making a Run on Wednesday

Why Infinity Pharmaceuticals Crashed

Analysts Very Positive on 3 Top Stocks Following Jefferies Healthcare Conference

Top Analyst Upgrades and Downgrades: Abbvie, Amazon, Cliffs Natural, Corning, Dynegy, Joy Global, Stanley Black & Decker and More

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan